New Program Launched to Identify Autoimmune Disease Therapies
A cross-disciplinary coalition of experts from academic centers across the United States is partnering with NIH, FDA, pharmaceutical companies and nonprofit organizations to identify new targets for therapies for autoimmune-meditated diseases.
Intranasal Flu Vaccine Developed with Nanoparticles
Researchers in a study funded by the National Institute of Allergy and Infectious Diseases and the National Institutes of Health have developed an influenza (flu) vaccine administered through the nose that has been constructed with nanoparticles and offers stronger protection.
Proposed Payment Systems and Fee Schedules in 2023
Proposed rules revising the Medicare Hospital Outpatient Prospective Payment System (OPPS) and the Medicare Ambulatory Surgical Center (ASC) services, along with new physician fee schedule (PFS) rule sets will significantly impact providers in 2023.
HHS Awards $1.5 Billion Grant to Combat Opioid Addiction
HHS (through SAMHSA) announced a State Opioid Response (SOR) grant funding of nearly $1.5 billion to help address the nation’s opioid addiction and overdose epidemic.
HHS Launches the Inaugural PandemicX 2022 Cohort
HHS has launched the PandemicX 2022 cohort, a program to accelerate private-public collaboration of 15 health tech startups.
NIH Establishes Antiviral Drug Discover Centers
NIH has awarded approximately $577 million to establish nine Antiviral Drug Discovery Centers for Pathogens of Pandemic Concern.
HHS and ED Launch Joint-Department Effort to Expand School-Based Health Services
The U.S. Department of Health and Human Services and U.S. Education Department have launched a joint-department effort to expand school-based health services.
New Test Detects and Measures Biomarkers in Blood Plasma to Earlier Diagnose Alzheimer’s
FDA has granted breakthrough device designation to Roche’s Elecsys Amyloid Plasma Panel, a new solution to enable Alzheimer’s disease to be detected earlier.
High-Dose IVIG Effective in Painful Diabetic Polyneuropathy Resistant to Conventional Treatments
Italian investigators conducted a trial to assess the safety and efficacy of IVIG in treatment-resistant painful diabetic polyneuropathy (DPN).
HHS Expands Funding for Mental Health and Substance Use Services
The Department of Health and Human Services (HHS) through the Substance Abuse and Mental Health Services Administration (SAMHSA) announced two Certified Community Behavioral Health Clinics (CCBHCs) funding opportunities to expand and increase access to evidence-based mental health and substance use services for Americans.
